As indicated by the findings of the study, KAT2A appeared to be capable of promoting DLBCL progression through its effects on proliferation, apoptosis, and cell cycle progression during the G2/M phase. This evidence concerns the gene KAT2A and diffuse large B-cell lymphoma.